These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1052290)

  • 1. Theoretical considerations on molecular transport in dialysis and sorbent therapy for uremia.
    Gotch FA; Farrell PC; Sargent J
    J Dial; 1976-1977; 1(2):105-44. PubMed ID: 1052290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urea and uremic solutes: how does peritoneal dialysis work?
    Bammens B
    Semin Nephrol; 2011 Mar; 31(2):127-37. PubMed ID: 21439427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of nitrogen removal mass in uremic patients on different modalities of dialysis therapy.
    Chen TW; Huang TP; Wang ML
    J Formos Med Assoc; 2000 Feb; 99(2):116-22. PubMed ID: 10770025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ["Clinical clearance" and "weekly clearance" of urea in periodical hemodialytic treatment].
    Ghezzi PM; Palanca R; Dutto A; Cento G
    Minerva Med; 1980 Oct; 71(39):2821-3. PubMed ID: 7432691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Assessment of nutrition in dialysis patients and chronic uremic patients].
    Liu H; Duan X; Li G
    Zhonghua Nei Ke Za Zhi; 1997 Nov; 36(11):727-30. PubMed ID: 10451942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rethinking the peritoneal dialysis prescription: results of recent studies.
    Bargman JM
    Nephrology (Carlton); 2006 Apr; 11(2):85-9. PubMed ID: 16669966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a system for sorbent-assisted peritoneal dialysis in a uremic pig model.
    van Gelder MK; de Vries JC; Simonis F; Monninkhof AS; Hazenbrink DHM; Ligabue G; Giovanella S; Joles JA; Verhaar MC; Bajo Rubio MA; Selgas R; Cappelli G; Gerritsen KGF
    Physiol Rep; 2020 Dec; 8(23):e14593. PubMed ID: 33278069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dialysis treatment of chronic kidney insufficiency in the uremic phase. Indications and limitations].
    Garini G; Savazzi G; Arisi L
    Recenti Prog Med; 1986 Sep; 77(9):440-3. PubMed ID: 3797795
    [No Abstract]   [Full Text] [Related]  

  • 10. Adequacy of peritoneal dialysis.
    Gotch FA
    Am J Kidney Dis; 1993 Jan; 21(1):96-8. PubMed ID: 8418636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should dialysis modalities be designed to remove specific uremic toxins?
    Baurmeister U; Vienken J; Ward RA
    Semin Dial; 2009; 22(4):454-7. PubMed ID: 19709001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein in the diets of dialyzed and non-dialyzed uremic patients. Study with nitrogen-labeled urea.
    Smith EB; Hill PA
    J Am Diet Assoc; 1972 May; 60(5):389-93. PubMed ID: 5018368
    [No Abstract]   [Full Text] [Related]  

  • 13. Profound mishandling of protein glycation degradation products in uremia and dialysis.
    Agalou S; Ahmed N; Babaei-Jadidi R; Dawnay A; Thornalley PJ
    J Am Soc Nephrol; 2005 May; 16(5):1471-85. PubMed ID: 15800128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A hypothesis: the protein catabolic rate is dependent upon the type and amount of treatment in dialyzed uremic patients.
    Lindsay RM; Spanner E
    Am J Kidney Dis; 1989 May; 13(5):382-9. PubMed ID: 2719025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tidal peritoneal dialysis: kinetics and protein balance.
    Flanigan MJ; Lim VS; Pflederer TA
    Am J Kidney Dis; 1993 Nov; 22(5):700-7. PubMed ID: 8238016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Quantitative evaluation of dialysis treatment. The priority of urea kinetic modelling].
    Simeonov P
    Vutr Boles; 1984; 23(2):7-12. PubMed ID: 6377704
    [No Abstract]   [Full Text] [Related]  

  • 17. Bowel as a kidney substitute in renal failure.
    Friedman EA
    Am J Kidney Dis; 1996 Dec; 28(6):943-50. PubMed ID: 8957051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sorbent membrane dialysis in uremia.
    Randerson DH; Gurland HJ; Schmidt B; Farrell PC; Hone PW; Stokoe C; Zuber A; Blogg A; Fateh-Moghadam A; Marschner I; Köpcke W
    Contrib Nephrol; 1982; 29():53-64. PubMed ID: 7075216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five years' experience of combination therapy: peritoneal dialysis with hemodialysis.
    Kawanishi H; Moriishi M; Tsuchiya S
    Adv Perit Dial; 2002; 18():62-7. PubMed ID: 12402589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A simplified approach to understanding urea kinetics in peritoneal dialysis and hemodialysis.
    Misra M; Nolph K
    Contrib Nephrol; 2006; 150():20-27. PubMed ID: 16720987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.